21 Myalgic Encephalomyelitis Clinical Trials in Salt Lake City, UT (2026)

Q: How do I join a clinical trial in Salt Lake City?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Salt Lake City research site will contact you.

Recruiting Myalgic Encephalomyelitis Studies in Salt Lake City

NCT05444582Recruiting

Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start

This is a prospective clinical research study to test the effectiveness of the Levonorgestrel (LNG) 52 mg Intrauterine Device (IUD) for emergency contraception (EC) and same-day start use that will en...

Salt Lake City, UTPHASE41,404 participantsUniversity of Utah

View Study Details

NCT06033599Recruiting

Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement

The purpose of this study is to 1) examine barriers and facilitators to implementation of MI and MORE for polysubstance use and evaluate strategies for optimizing training, fidelity, and clinic uptake...

Salt Lake City, UTPHASE3420 participantsRutgers, The State University of New Jersey

View Study Details

NCT06883045Recruiting

A Novel mHealth Intervention to Improve Outcomes of Children With Medical Complexity

Children with medical complexity (CMC) are the most vulnerable of children with chronic diseases, who have complex, multisystem chronic diseases affecting ≥3 organ systems, severe functional limitatio...

Salt Lake City, UTNA360 participantsUniversity of Utah

View Study Details

NCT06112990Recruiting

Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression

The goal of this clinical trial is to test the use of creatine monohydrate supplementation with resistance training to preserve muscle mass and help lessen prostate cancer progression. The main quest...

Salt Lake City, UTPHASE3200 participantsUniversity of Utah

View Study Details

NCT03422198Recruiting

Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer

This randomized phase III trial studies short course vaginal cuff brachytherapy to see how well it works compared with standard of care vaginal cuff brachytherapy in treating participants with stage I...

Salt Lake City, UTPHASE3188 participantsUniversity of Utah

View Study Details

NCT07436793Recruiting

Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial

This phase II trial tests compares the effect of progestins, megestrol acetate to micronized progesterone, in treating patients with endometrial cancer and precancers of the uterus (atypical endometri...

Salt Lake City, UTPHASE2140 participantsNew Mexico Cancer Research Alliance

View Study Details

NCT04683653Recruiting

Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer

This study will investigate if a shorter treatment course (known as "hypofractionation") for pelvic radiation is safe for women with endometrial cancer. Doctors leading the study will also determine t...

Salt Lake City, UTPHASE1100 participantsUniversity of Chicago

View Study Details

NCT06607458Recruiting

Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease

The goal of this clinical trial is to learn if using a liver-directed therapy with high dose chemotherapy followed by approved cancer treatment to treat patients with colorectal cancer that has spread...

Salt Lake City, UTPHASE290 participantsDelcath Systems Inc.

View Study Details

NCT07203378Recruiting

Nurturing Exercise Routine for Greater Improvement in Zest and Energy on Enhertu

The goal of this study is to test the efficacy of using a 12-week, home-based, unsupervised aerobic and resistance training exercise program for changes in cancer-related fatigue in patients with meta...

Salt Lake City, UTPHASE280 participantsUniversity of Utah

View Study Details

NCT06782373Recruiting

A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)

This study is to assess the effectiveness and safety of pacritinib in patients with VEXAS (i.e., Vacuoles in myeloid progenitors, E1 ubiquitin-activating enzyme, X-linked, autoinflammatory manifestati...

Salt Lake City, UTPHASE278 participantsSwedish Orphan Biovitrum

View Study Details

NCT05900466Recruiting

Metformin for Fibromyalgia Symptoms (INFORM Trial)

The main purpose of the project is to evaluate the safety and efficacy of low dose metformin for improving symptoms associated with fibromyalgia syndrome (FMS) via modulating neuroinflammatory pathway...

Salt Lake City, UTPHASE272 participantsUniversity of Utah

View Study Details

NCT07142252Recruiting

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

This Phase 2 study is a 2-arm, multi-center, double-masked (masking of the participant, care provider and investigator), placebo-controlled, 2:1 randomized trial design in new onset T1D participants (...

Salt Lake City, UTPHASE266 participantsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

View Study Details

NCT05371613Recruiting

A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric and Young Adult Participants With Neuronopathic (nMPS II) or Non-Neuronopathic Mucopolysaccharidosis Type II (nnMPS II)

This is a Phase 2/3, multiregional, two-arm, double-blind, randomized, active (standard-of-care)-controlled study of the efficacy and safety of tividenofusp alfa (DNL310), an investigational central n...

Salt Lake City, UTPHASE263 participantsDenali Therapeutics Inc.

View Study Details

NCT03152058Recruiting

IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy

This treatment trial evaluates the addition of an anti-tumor necrosis factor-alpha drug, certolizumab, to usual treatment (a heparin agent and low-dose aspirin) in pregnant women with antiphospholipid...

Salt Lake City, UTPHASE255 participantsDavid Ware Branch

View Study Details

NCT03646617Recruiting

Ipilumumab and Nivolumab With or Without Hypofractionated Radiotherapy in Patients With Metastatic Melanoma

The main purpose of this study is to determine the safety of combining ipilimumab and nivolumab with hypofractionated radiotherapy to a single tumor in patients with metastatic melanoma. Another purpo...

Salt Lake City, UTPHASE254 participantsAbramson Cancer Center at Penn Medicine

View Study Details

NCT06194929Recruiting

Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma

The goal of this interventional clinical trial is to provide proof-of-principle data for the biologic activity of defactinib in combination with avutometinib in brain metastases from melanoma, and to ...

Salt Lake City, UTPHASE133 participantsUniversity of Utah

View Study Details

NCT06568562Recruiting

XL092 in Patients With Metastatic Castration-Resistant Prostate Cancer

The purpose of this study is to determine how well the study drug XL092 is helping to treat a participant's cancer after 16 weeks of treatment. Researchers will also look at how safe the XL092 is and ...

Salt Lake City, UTPHASE232 participantsUniversity of Utah

View Study Details

NCT06365619Recruiting

Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma

The goal of this clinical trial is to study the impact of Neoadjuvant ipilimumab and nivolumab for melanoma patients that had recurrence during or after adjuvant anti-PD-1 therapy. Participants will ...

Salt Lake City, UTPHASE225 participantsUniversity of Utah

View Study Details

NCT05873712Recruiting

Zanubrutinib and Lisocabtagene Maraleucel for the Treatment of Richter's Syndrome

This phase II trial tests how well zanubrutinib and lisocabtagene maraleucel (liso-cel) work together in treating patients with Richter's syndrome. Richter's syndrome occurs when chronic lymphocytic l...

Salt Lake City, UTPHASE224 participantsAseel Alsouqi

View Study Details

NCT06907875Recruiting

A First-in-human Study of EPI-321 in Facioscapulohumeral Muscular Dystrophy

The goal of this clinical trial is to learn how safe and tolerable EPI-321 is and whether there may be early signs it is working in male or female adult (18 to 75 years) participants with facioscapulo...

Salt Lake City, UTPHASE112 participantsEpicrispr Biotechnologies, Inc.

View Study Details

NCT03801434Recruiting

Ruxolitinib in Treating Patients with Hypereosinophilic Syndrome or Primary Eosinophilic Disorders

This phase II trial studies how well ruxolitinib works in treating patients with hypereosinophilic syndrome or primary eosinophilic disorders....

Salt Lake City, UTPHASE210 participantsWilliam Shomali

View Study Details

About Myalgic Encephalomyelitis Clinical Trials in Salt Lake City

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 21 myalgic encephalomyelitis clinical trials recruiting participants in Salt Lake City, UT. These studies are seeking a combined 3,506 participants. Research is being sponsored by University of Utah, Rutgers, The State University of New Jersey, New Mexico Cancer Research Alliance and 10 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in Salt Lake City — FAQ

Are there myalgic encephalomyelitis clinical trials in Salt Lake City?

Yes, there are 21 myalgic encephalomyelitis clinical trials currently recruiting in Salt Lake City, UT. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Salt Lake City?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Salt Lake City research site will contact you about next steps.

Are clinical trials in Salt Lake City free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Salt Lake City studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 21 active trials in Salt Lake City are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated July 17, 2026 from ClinicalTrials.gov